IOL CHEMICALS & PHARM. | ALKEM LABORATORIES | IOL CHEMICALS & PHARM./ ALKEM LABORATORIES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 35.8 | 38.4% | View Chart |
P/BV | x | 1.6 | 6.2 | 25.1% | View Chart |
Dividend Yield | % | 1.0 | 1.1 | 93.9% |
IOL CHEMICALS & PHARM. ALKEM LABORATORIES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
ALKEM LABORATORIES Mar-23 |
IOL CHEMICALS & PHARM./ ALKEM LABORATORIES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 3,625 | 14.8% | |
Low | Rs | 272 | 2,835 | 9.6% | |
Sales per share (Unadj.) | Rs | 377.6 | 970.1 | 38.9% | |
Earnings per share (Unadj.) | Rs | 23.7 | 84.2 | 28.1% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 110.2 | 28.6% | |
Dividends per share (Unadj.) | Rs | 4.00 | 50.00 | 8.0% | |
Avg Dividend yield | % | 1.0 | 1.5 | 63.9% | |
Book value per share (Unadj.) | Rs | 256.8 | 756.4 | 33.9% | |
Shares outstanding (eoy) | m | 58.71 | 119.57 | 49.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 3.3 | 32.2% | |
Avg P/E ratio | x | 17.1 | 38.4 | 44.5% | |
P/CF ratio (eoy) | x | 12.8 | 29.3 | 43.7% | |
Price / Book Value ratio | x | 1.6 | 4.3 | 36.9% | |
Dividend payout | % | 16.9 | 59.4 | 28.4% | |
Avg Mkt Cap | Rs m | 23,743 | 386,207 | 6.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 21,314 | 7.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 115,993 | 19.1% | |
Other income | Rs m | 256 | 2,161 | 11.9% | |
Total revenues | Rs m | 22,427 | 118,153 | 19.0% | |
Gross profit | Rs m | 2,257 | 15,065 | 15.0% | |
Depreciation | Rs m | 462 | 3,104 | 14.9% | |
Interest | Rs m | 165 | 1,074 | 15.3% | |
Profit before tax | Rs m | 1,887 | 13,048 | 14.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 2,980 | 16.6% | |
Profit after tax | Rs m | 1,391 | 10,068 | 13.8% | |
Gross profit margin | % | 10.2 | 13.0 | 78.4% | |
Effective tax rate | % | 26.2 | 22.8 | 114.9% | |
Net profit margin | % | 6.3 | 8.7 | 72.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 86,064 | 11.2% | |
Current liabilities | Rs m | 5,025 | 37,071 | 13.6% | |
Net working cap to sales | % | 20.9 | 42.2 | 49.6% | |
Current ratio | x | 1.9 | 2.3 | 82.9% | |
Inventory Days | Days | 43 | 33 | 132.8% | |
Debtors Days | Days | 8 | 67 | 12.4% | |
Net fixed assets | Rs m | 11,017 | 37,245 | 29.6% | |
Share capital | Rs m | 587 | 239 | 245.5% | |
"Free" reserves | Rs m | 14,490 | 90,208 | 16.1% | |
Net worth | Rs m | 15,077 | 90,447 | 16.7% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 124,541 | 16.6% | |
Interest coverage | x | 12.5 | 13.2 | 94.7% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.9 | 115.1% | |
Return on assets | % | 7.5 | 8.9 | 84.1% | |
Return on equity | % | 9.2 | 11.1 | 82.9% | |
Return on capital | % | 13.6 | 15.6 | 87.1% | |
Exports to sales | % | 26.7 | 14.6 | 183.4% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | 16,916 | 35.1% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 16,916 | 35.1% | |
Fx outflow | Rs m | 6,052 | 4,190 | 144.5% | |
Net fx | Rs m | -122 | 12,727 | -1.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 16,825 | 7.3% | |
From Investments | Rs m | -1,200 | 1,128 | -106.3% | |
From Financial Activity | Rs m | -41 | -17,608 | 0.2% | |
Net Cashflow | Rs m | -18 | 416 | -4.4% |
Indian Promoters | % | 48.2 | 56.7 | 84.9% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 24.7 | 6.9% | |
FIIs | % | 1.4 | 9.1 | 15.4% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 43.3 | 119.8% | |
Shareholders | 130,003 | 65,830 | 197.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | ALKEM LABORATORIES | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.40% | 0.24% | 0.27% |
1-Month | 6.23% | -5.80% | 1.38% |
1-Year | 1.15% | 37.33% | 54.30% |
3-Year CAGR | -12.75% | 19.00% | 14.78% |
5-Year CAGR | 16.32% | 22.22% | 19.39% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the ALKEM LABORATORIES share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of ALKEM LABORATORIES the stake stands at 56.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of ALKEM LABORATORIES.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
ALKEM LABORATORIES paid Rs 50.0, and its dividend payout ratio stood at 59.4%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of ALKEM LABORATORIES.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets continued the momentum as the session progressed and ended the higher.